chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: COVID-19 positive; Lack of drug effect; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (COVID-19 positive) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Codeine and Morphine) and Blood pressure high.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Oct-2022, the patient experienced COVID-19 (COVID-19 positive) (seriousness criterion hospitalization) and VACCINATION FAILURE (Lack of drug effect). The patient was hospitalized for 10 days due to COVID-19. At the time of the report, COVID-19 (COVID-19 positive) outcome was unknown and VACCINATION FAILURE (Lack of drug effect) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Oct-2022, SARS-CoV-2 test: Positive.         Patient was on other medication consumption.   Before she got the booster, she got COVID-19.  Reporter believed that the patient received antibiotics as a treatment.  Company Comment:  This is a spontaneous case concerning a 93-year-old, female patient with no relevant medical history, who experienced the unexpected serious event of COVID-19 which required hospitalization for 10 days. The event occurred 1 year and a half after the administration of the second dose of mRNA-1273 vaccine. Vaccination failure is also consider in this case. Treatment recevied was not reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 93-year-old, female patient with no relevant medical history, who experienced the unexpected serious event of COVID-19 which required hospitalization for 10 days. The event occurred 1 year and a half after the administration of the second dose of mRNA-1273 vaccine. Vaccination failure is also consider in this case. Treatment recevied was not reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vial was at room temperature for 25 hours; No Adverse event; bivalent vaccine given to patient from a vial punctured more than 12 hours ago; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent vaccine given to patient from a vial punctured more than 12 hours ago), PRODUCT STORAGE ERROR (Vial was at room temperature for 25 hours) and NO ADVERSE EVENT (No Adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 059F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent vaccine given to patient from a vial punctured more than 12 hours ago). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was at room temperature for 25 hours) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent vaccine given to patient from a vial punctured more than 12 hours ago), PRODUCT STORAGE ERROR (Vial was at room temperature for 25 hours) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent vaccine given to patient from a vial punctured more than 12 hours ago) and PRODUCT STORAGE ERROR (Vial was at room temperature for 25 hours).    Patients were all over the age of 65. No concomitant medication were reported.   Patient received Bivalent vaccine. Vial size was 5.5ml The vial was initially stored in the refrigerator on 12-OCT-2022. The vial was first punctured on 19-OCT-2022 10:00AM. The vaccine was administered on 20-OCT-2022 at 10:13, 10:15 and 11:00 respectively for 3 patients. The vial was stored at room temperature post puncture .  The vial did not undergo any temperature excursions. The vial was exposed to room temperature range for just over 25 hours.  No treatment information was provided by the reporter. This case was for first patient out of 3 patients described by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-661792, US-MODERNATX, INC.-MOD-2022-661793 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-661793:Patient 3 US-MODERNATX, INC.-MOD-2022-661792:patient 2
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Vaccination site pain
Clinical narrative: pain in his shoulder,pain from his elbow to his neck.; pain in his shoulder,pain from his elbow to his neck.; Her husband still had pain in his left arm which is where her received the Moderna Booster dose; This spontaneous case was reported by a patient family member or friend and describes the occurrence of NECK PAIN (pain in his shoulder,pain from his elbow to his neck.), ARTHRALGIA (pain in his shoulder,pain from his elbow to his neck.) and VACCINATION SITE PAIN (Her husband still had pain in his left arm which is where her received the Moderna Booster dose) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012S21A, 045A21A and 022H20A) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetes. Concomitant products included TIZANIDINE, CODEINE, PARACETAMOL (APAP/CODEINE [CODEINE;PARACETAMOL]), GABAPENTIN and INSULIN for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (pain in his shoulder,pain from his elbow to his neck.), ARTHRALGIA (pain in his shoulder,pain from his elbow to his neck.) and VACCINATION SITE PAIN (Her husband still had pain in his left arm which is where her received the Moderna Booster dose). At the time of the report, NECK PAIN (pain in his shoulder,pain from his elbow to his neck.), ARTHRALGIA (pain in his shoulder,pain from his elbow to his neck.) and VACCINATION SITE PAIN (Her husband still had pain in his left arm which is where her received the Moderna Booster dose) had not resolved.      The reporter stated like patient had no adverse reactions after first and second Moderna vaccination. It was reported the pain became so severe that the patient went to go see a pain specialist. The patient was prescribed pain medications and muscle relaxants, and these did not work so the physician tried steroid injections. The caller said that her husband still had pain in his left arm.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Incorrect dose administered, No adverse event
Clinical narrative: No adverse event; accidentally gave a booster dose before the patient completed the primary series; greater than 36 days since first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (accidentally gave a booster dose before the patient completed the primary series), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days since first dose) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days since first dose). On 20-Oct-2022, the patient experienced INCORRECT DOSE ADMINISTERED (accidentally gave a booster dose before the patient completed the primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (accidentally gave a booster dose before the patient completed the primary series), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days since first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INCORRECT DOSE ADMINISTERED (accidentally gave a booster dose before the patient completed the primary series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days since first dose).    No Concomitant medications were provided. It was reported that pharmacist was calling because they accidentally gave a booster dose before the patient completed the primary series. The patient received first dose of Moderna on 17 Mar 2021. No treatment medications were provided.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Fatigue, Pain in extremity, Vaccination site pain
Clinical narrative: Face burn; Left hand was sore; The vaccine made it worst, and it went down all the way to her hand; She was tired; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Patient had no medical history both acute and chronic illnesses at the time of vaccination.  Patient never had COVID-19 positive test or diagnosis.  Concurrent medical conditions included Gluten sensitivity, Soy allergy, Peanut allergy, Allergy to nuts, Food allergy, Allergy to chemicals, Egg allergy, Sesame allergy, Shellfish allergy and Drug allergy. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (MICROGESTIN) and LEVOTHYROXINE SODIUM (TIROSINT SOL) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired). At the time of the report, BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient did not had any other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  Patient was taking other (unspecified) medication when she received the 1st shot. Patient's HCP was aware of the vaccine side effects.  No treatment medication reported.   This case was linked to MOD-2022-662107, MOD-2022-662108 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Decreased appetite, Dysstasia, Feeling cold, Feeling hot
Clinical narrative: Face burn; Left hand was sore; The vaccine made it worst, and it went down all the way to her hand; She was tired; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Patient had no medical history both acute and chronic illnesses at the time of vaccination.  Patient never had COVID-19 positive test or diagnosis.  Concurrent medical conditions included Gluten sensitivity, Soy allergy, Peanut allergy, Allergy to nuts, Food allergy, Allergy to chemicals, Egg allergy, Sesame allergy, Shellfish allergy and Drug allergy. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (MICROGESTIN) and LEVOTHYROXINE SODIUM (TIROSINT SOL) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired). At the time of the report, BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient did not had any other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  Patient was taking other (unspecified) medication when she received the 1st shot. Patient's HCP was aware of the vaccine side effects.  No treatment medication reported.   This case was linked to MOD-2022-662107, MOD-2022-662108 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Influenza like illness, Mobility decreased, Muscle spasms, Nausea
Clinical narrative: Face burn; Left hand was sore; The vaccine made it worst, and it went down all the way to her hand; She was tired; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Patient had no medical history both acute and chronic illnesses at the time of vaccination.  Patient never had COVID-19 positive test or diagnosis.  Concurrent medical conditions included Gluten sensitivity, Soy allergy, Peanut allergy, Allergy to nuts, Food allergy, Allergy to chemicals, Egg allergy, Sesame allergy, Shellfish allergy and Drug allergy. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (MICROGESTIN) and LEVOTHYROXINE SODIUM (TIROSINT SOL) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired). At the time of the report, BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient did not had any other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  Patient was taking other (unspecified) medication when she received the 1st shot. Patient's HCP was aware of the vaccine side effects.  No treatment medication reported.   This case was linked to MOD-2022-662107, MOD-2022-662108 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Paraesthesia, Somnolence
Clinical narrative: Face burn; Left hand was sore; The vaccine made it worst, and it went down all the way to her hand; She was tired; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Patient had no medical history both acute and chronic illnesses at the time of vaccination.  Patient never had COVID-19 positive test or diagnosis.  Concurrent medical conditions included Gluten sensitivity, Soy allergy, Peanut allergy, Allergy to nuts, Food allergy, Allergy to chemicals, Egg allergy, Sesame allergy, Shellfish allergy and Drug allergy. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (MICROGESTIN) and LEVOTHYROXINE SODIUM (TIROSINT SOL) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired). At the time of the report, BURNING SENSATION (Face burn), VACCINATION SITE PAIN (Left hand was sore), PAIN IN EXTREMITY (The vaccine made it worst, and it went down all the way to her hand) and FATIGUE (She was tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient did not had any other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  Patient was taking other (unspecified) medication when she received the 1st shot. Patient's HCP was aware of the vaccine side effects.  No treatment medication reported.   This case was linked to MOD-2022-662107, MOD-2022-662108 (Patient Link).
Sex: F
Vaccine: COVID19, UNK
Symptoms: Body temperature, Lethargy, Pyrexia
Clinical narrative: lethargy; ran a slight fever, 101F; This spontaneous case was reported by a patient and describes the occurrence of LETHARGY (lethargy) and PYREXIA (ran a slight fever, 101F) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product PALBOCICLIB (IBRANCE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and PALBOCICLIB (IBRANCE) (unknown route) at an unspecified dose. On an unknown date, the patient experienced LETHARGY (lethargy) and PYREXIA (ran a slight fever, 101F). At the time of the report, LETHARGY (lethargy) and PYREXIA (ran a slight fever, 101F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 101 F.         No concomitant medications were reported.   It was reported that, after receiving the 1st booster dose of the Moderna COVID-19 vaccine, the patient experienced a little reaction: lethargy and ran a slight fever. The patient referred to healthcare professional for treatment recommendations.  No treatment details were reported.
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Paralysis
Clinical narrative: stroke; Paralysis; This spontaneous case was reported by a patient family member or friend and describes the occurrence of CEREBROVASCULAR ACCIDENT (stroke) and PARALYSIS (Paralysis) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CEREBROVASCULAR ACCIDENT (stroke) (seriousness criterion medically significant) and PARALYSIS (Paralysis) (seriousness criterion medically significant). At the time of the report, CEREBROVASCULAR ACCIDENT (stroke) and PARALYSIS (Paralysis) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. Caller reported that her father had Stroke and Paralysis after taking the vaccine. No treatment medications were reported. COMPANY COMMENT: This spontaneous case concerns a male patient of unknown age with no medical history reported, who experienced the unexpected, serious (medically significant) events of Cerebrovascular accident (AESI) and paralysis, which occurred after dose mRNA-1273 administration, which was unknown dose in COVID-19 vaccination schedule. Latency cannot be assessed as date of vaccination and events onset dates are not known. No further clinical information or details about course of the event was provided for medical review. The outcome of the events was not known at the time of the report. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Events' seriousness was assessed as per the  Medicines Agency list of important medical events.   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a male patient of unknown age with no medical history reported, who experienced the unexpected, serious (medically significant) events of Cerebrovascular accident (AESI) and paralysis, which occurred after dose mRNA-1273 administration, which was unknown dose in COVID-19 vaccination schedule. Latency cannot be assessed as date of vaccination and events onset dates are not known. No further clinical information or details about course of the event was provided for medical review. The outcome of the events was not known at the time of the report. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Events' seriousness was assessed as per the Agency list of important medical events.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Hot flush, Influenza like illness, Lymphadenopathy
Clinical narrative: face burn just a little bit; had minor flu like symptoms; Lymph nodes swell up; hot flashes increase in number; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (face burn just a little bit), INFLUENZA LIKE ILLNESS (had minor flu like symptoms), HOT FLUSH (hot flashes increase in number) and LYMPHADENOPATHY (Lymph nodes swell up) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001J212A) for COVID-19 prophylaxis.     Patient had no history of COVID positive test or diagnosis. Patient had no history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. Patient did not receive any other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Gluten intolerance, Soy allergy, Allergy to nuts (tree nuts), Peanut allergy, Vegetable allergy (tomatoes), Allergy to chemicals (coloring dyes), Egg allergy, Sesame allergy, Shellfish allergy, Drug allergy (Oxycodone) and Postmenopause. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (MICROGESTIN) and LEVOTHYROXINE SODIUM (TIROSINT) for an unknown indication.    On 28-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (face burn just a little bit), INFLUENZA LIKE ILLNESS (had minor flu like symptoms), HOT FLUSH (hot flashes increase in number) and LYMPHADENOPATHY (Lymph nodes swell up). At the time of the report, BURNING SENSATION (face burn just a little bit) and LYMPHADENOPATHY (Lymph nodes swell up) outcome was unknown and INFLUENZA LIKE ILLNESS (had minor flu like symptoms) and HOT FLUSH (hot flashes increase in number) had resolved.            Patient had received Moderna vaccine 1st dose on 14Apr2021, left arm IM with lot no 040B21A and 2nd dose on 12May2022 left arm IM with lot no 014C21A.  Patient received half dose of 1st booster in left arm (a little higher up in the muscle). Patient had minor flu like symptoms for a day and half. Patient experienced hot flashes increased in number and had severity for 4 months.  No treatment information was provided by the reporter.    This case was linked to MOD-2022-662107, MOD-2022-662027 (Patient Link).
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for COVID-19) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048621A, 088D21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to chemicals (Sulfur).   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In October 2022, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Oct-2022, SARS-CoV-2 test: (Positive) Positive.         The patient had no acute and chronic illnesses at the time of vaccination. The patient had no other vaccines given within 1 month prior to Moderna COVID-19 vaccine. On 02-Nov-2021, the patient received the 1st booster dose of Moderna COVID-19 vaccine.  On 30-Mar-2022, the patient received the 2nd booster dose of Moderna COVID-19 vaccine. It was reported that COVID-19 symptoms began on 05/06-Oct-2022. The patient did not remember how he got it. The patient was isolated for 5 days as recommended by the  On 12-Oct-2022, patient left the house to go shopping for food with mask on. The patient had not received the treatment for COVID-19.
Age: 6.0
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose, No adverse event
Clinical narrative: No Adverse Event; Accidentally administered a 0.5mL dose of the Moderna COVID 19 bivalent vaccine to a child; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Accidentally administered a 0.5mL dose of the Moderna COVID 19 bivalent vaccine to a child) and NO ADVERSE EVENT (No Adverse Event) in a 6-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     Patient had no allergies.     On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 21-Oct-2022, the patient experienced ACCIDENTAL OVERDOSE (Accidentally administered a 0.5mL dose of the Moderna COVID 19 bivalent vaccine to a child). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, ACCIDENTAL OVERDOSE (Accidentally administered a 0.5mL dose of the Moderna COVID 19 bivalent vaccine to a child) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for ACCIDENTAL OVERDOSE (Accidentally administered a 0.5mL dose of the Moderna COVID 19 bivalent vaccine to a child).    Not on any concomitant medications. Patient accidentally got a 0.5mL dose of the Moderna COVID 19 bivalent vaccine instead of 0.25mL dose. No treatment medication was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No adverse event; Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 21-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster).    Concomitant medications details were not reported by the reporter.  No AEs were reported.  Treatment details was not reported by the reporter.   This case was linked to MODERNATX, INC.-MOD-2022-662391, MODERNATX, INC.-MOD-2022-662390, MODERNATX, INC.-MOD-2022-662385 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2022-662390:same reporter MODERNATX, INC.-MOD-2022-662391:same reporter MODERNATX, INC.-MOD-2022-662385:same reporter
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a patient and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2022, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, SARS-CoV-2 test: Positive.         It was reported that the patient was taking other medication. The patient had 4 shots of the Moderna vaccine. He had the initial 2 shots and 1 booster.  After the 1st booster in Oct-2021, he got COVID-19 in Jan-2022, two months later. He had a monoclonal infusion antibody treatment.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No adverse event; Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 55-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 21-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster).    No concomitant medications were reported. No treatment details were reported.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: No adverse event; Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 37-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 21-Oct-2022, the patient experienced UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster).    No concomitant medications were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-662391 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-662391:same reporter US-MODERNATX, INC.-MOD-2022-662390:same reporter
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No adverse event; Patient administered with dose of 0.25 mL instead of 0.50 mL of  bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient administered with dose of 0.25 mL instead of 0.50 mL of  bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 48-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 21-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient administered with dose of 0.25 mL instead of 0.50 mL of  bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient administered with dose of 0.25 mL instead of 0.50 mL of  bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient administered with dose of 0.25 mL instead of 0.50 mL of  bivalent booster).    No concomitant medications were reported.  Reporter mentioned that no AEs were reported.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-662391, US-MODERNATX, INC.-MOD-2022-662377, US-MODERNATX, INC.-MOD-2022-662382, US-MODERNATX, INC.-MOD-2022-662383, US-MODERNATX, INC.-MOD-2022-662384, US-MODERNATX, INC.-MOD-2022-662386, US-MODERNATX, INC.-MOD-2022-662387, US-MODERNATX, INC.-MOD-2022-662388, US-MODERNATX, INC.-MOD-2022-662389, US-MODERNATX, INC.-MOD-2022-662390 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-662391:same reporter US-MODERNATX, INC.-MOD-2022-662377:same reporter US-MODERNATX, INC.-MOD-2022-662382:same reporter US-MODERNATX, INC.-MOD-2022-662383:Same reporter US-MODERNATX, INC.-MOD-2022-662384:Same reporter US-MODERNATX, INC.-MOD-2022-662386:Same reporter US-MODERNATX, INC.-MOD-2022-662387:Same reporter US-MODERNATX, INC.-MOD-2022-662388:Same reporter US-MODERNATX, INC.-MOD-2022-662389:Same reporter US-MODERNATX, INC.-MOD-2022-662390:Same reporter
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No adverse event; patients administered with doses of 0.25 mL instead of 0.50 mL of bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (patients administered with doses of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 21-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (patients administered with doses of 0.25 mL instead of 0.50 mL of bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (patients administered with doses of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (patients administered with doses of 0.25 mL instead of 0.50 mL of bivalent booster).    No concomitant medication was reported.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-662390 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-662390:same reporter
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No adverse event; Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 67-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 21-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster).    Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-662391, US-MODERNATX, INC.-MOD-2022-662390, US-MODERNATX, INC.-MOD-2022-662385 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-662391:same reporter US-MODERNATX, INC.-MOD-2022-662390:same reporter US-MODERNATX, INC.-MOD-2022-662385:Same reporter
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No adverse event; Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 68-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 21-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient administered with doses of 0.25 mL instead of 0.50 mL of  bivalent booster).    No concomitant medication details was reported.  No treatment medication details was reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No adverse event; Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 59-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 21-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered with dose of 0.25 mL instead of 0.50 mL of bivalent booster).    The concomitant medication was not reported by reporter. No AEs were reported. The treatment medication was not reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-662391, US-MODERNATX, INC.-MOD-2022-662377, US-MODERNATX, INC.-MOD-2022-662382, US-MODERNATX, INC.-MOD-2022-662383, US-MODERNATX, INC.-MOD-2022-662384, US-MODERNATX, INC.-MOD-2022-662386, US-MODERNATX, INC.-MOD-2022-662387, US-MODERNATX, INC.-MOD-2022-662389 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-662391:same reporter US-MODERNATX, INC.-MOD-2022-662377:same reporter US-MODERNATX, INC.-MOD-2022-662382:same reporter US-MODERNATX, INC.-MOD-2022-662383:same reporter US-MODERNATX, INC.-MOD-2022-662384:same reporter US-MODERNATX, INC.-MOD-2022-662386:same reporter US-MODERNATX, INC.-MOD-2022-662387:same reporter US-MODERNATX, INC.-MOD-2022-662389:same reporter